ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (19.4), the stock would be worth ¥-2.37 (116% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -125.1 | ¥15.27 |
0%
|
| 3-Year Average | 19.4 | ¥-2.37 |
-116%
|
| 5-Year Average | 25.8 | ¥-3.15 |
-121%
|
| Industry Average | 24.8 | ¥-3.03 |
-120%
|
| Country Average | 28.8 | ¥-3.52 |
-123%
|
Forward EV/EBITDA
Today’s price vs future ebitda
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
|
6.1B CNY | -125.1 | -92.4 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
65.1B ZAR | 9.8 | 20.1 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
30.7B ZAR | 15.7 | 24.8 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | 3 | -1.6 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
38.5B BRL | 9.7 | 30.2 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
929.3B JPY | 9.4 | 21.8 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
911.6B JPY | 7.6 | 16.3 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 10.2 | 20.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
29.9B CNY | 10.3 | 17.3 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 9.1 | 34.3 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
574.6B JPY | 8.1 | 12.8 |
Market Distribution
| Min | 0 |
| 30th Percentile | 16.3 |
| Median | 28.8 |
| 70th Percentile | 53.1 |
| Max | 49 021 |
Other Multiples
ShuYu Civilian Pharmacy Corp Ltd
Glance View
ShuYu Civilian Pharmacy Corp., Ltd. engages in the operation of pharmaceutical retail chain businesses. The company is headquartered in Jinan, Shandong and currently employs 11,023 full-time employees. The company went IPO on 2021-07-05. The firm's main business includes the operation and sales of Chinese and western patent medicines, health foods, Chinese medicine decoction pieces and health equipment. Main customers of the Company's retail business are end consumers. The firm's direct chain stores are mainly located in Shandong Province, China.